U.S. Patent Office Awards Diffusion Exclusive Rights for Use of TSC in Conjunction with Only FDA-Approved Stroke Therapeutic
FDA Approves Start of Innovative On-Ambulance Phase 2 Clinical Trial for Treatment of Acute Stroke by Diffusion Pharmaceuticals
pharmaceutical investing Diffusion Pharmaceuticals Announces Validation of European Patent for Oral Formulations of TSC
Churchill Discovers 20 Gold-Silver-Molybdenum-Lead-Zinc Veins Within a 150m Wide Swarm at Pomley Cove Pond, Black Raven Property
